“Along with our principals’ operating experience in building and managing successful companies, we believe Amy’s unique expertise, experience, and relationships give us a distinct advantage in recognizing the most promising and innovative businesses in the sector.” Seeking opportunities from psychedelic medicine to brainwave devices and more
#Satori capital professional#
“Amy’s experience and subject matter expertise, as well as her impressive professional background, position her ideally to lead this innovative neuroscience and mental-health-related strategy,” Satori co-founder and managing partner Randy Eisenman said in the statement. in neuroscience from the University of Illinois Urbana-Champaign. Kruse has both a Bachelor of Science in cell and structural biology and a Ph.D. Previously, she served as chief scientific officer of applied neuroscience research company Optios, and she has prior experience as chief technology officer of Cubic Global Defense and as a program manager at the Defense Advanced Research Projects Agency (DARPA). She’s a former general partner at Jackson, Wyoming-based Prime Movers Lab, a VC firm that invests in early-stage scientific-driven startups. Kruse has more than 20 years of experience in science, technology, and innovation, with a special focus on neurotechnology and human performance, Satori said. Amy Kruze as managing partner and chief investment officer of Satori Neuro. Amy Kruse to be the managing partner and CIOĪfter a widespread search, Satori appointed Dr. “Because we believe so strongly in the tremendous potential of these innovative solutions, we decided that if we could find the ideal chief investment officer to lead a focused strategy, we would explore it ourselves.” Dr. “We’ve spent a significant amount of time and resources over the last several years evaluating mental-health-related opportunities,” James Haddaway, chief investment officer and managing partner of Satori Alpha, said in a statement. The investment firm says the new business aligns with Satori’s purpose of creating, funding, and inspiring “businesses that elevate humanity.” Satori Neuro will target companies developing breakthrough treatments and disruptive business models to address “the world’s most critical mental health challenges,” Satori said. Dallas- and Fort Worth-based Satori Capital has launched a new investment business focused on “transformational companies developing innovative solutions for mental health.”
0 kommentar(er)
